Jack Harley, Therapeutic Neuroscience at Oxford University
reviewed by Dr Michael Yapko
Tuesday, April 7, 2020
Jack Harley, Therapeutic Neuroscience at Oxford University
Tuesday, April 7, 2020

Coronavirus and IBS Symptoms


The COVID-19 pandemic has taken the world by storm and become a global pandemic. The flu-like symptoms are well known, such as dry cough and fever, however, the gastrointestinal (GI) symptoms are less widely acknowledged. Symptoms such as diarrhoea and loss of appetite occur in up to half of patients with coronavirus, and it is crucial that these symptoms are made known (1). This article explains the digestive issues caused by the Coronavirus and compares them to symptoms of irritable bowel syndrome (IBS), a condition experienced by 1 in 7 people globally (2).

What are the GI symptoms of Coronavirus?

Many zoonotic viruses like SARS and MERS that have jumped from animals to humans can wreak havoc across the whole body, not just in the lungs (3). Coronavirus is no different, and over 50% of patients experience gastrointestinal symptoms. These include:

  • Loss of appetite
  • Nausea
  • Diarrhea
  • Abdominal pain (1,3)

Loss of appetite is the most common digestive symptom in IBS and experienced by 84% of COVID-19 patients. Diarrhea was also a common symptom, appearing in approximately one third of patients (1).

What are the GI symptoms of IBS?

Irritable bowel syndrome is a very common gastrointestinal disorder affecting up to 45 million people in the US alone (4). Many of the symptoms overlap with COVID-19 and include:

  • Abdominal discomfort and pain
  • Bloating and gas
  • Diarrhea/constipation
  • Cramping (4)

These symptoms may have a severe toll on a person’s wellbeing. However, unlike celiac disease, Crohn’s disease or ulcerative colitis, IBS usually does not cause long-term damage to the digestive tract. Below is a comparison of Coronavirus GI symptoms and IBS symptoms.

Calm your IBS in just 6 weeks with Nerva

Start Now
Self-guided gut hypnotherapy
Developed by doctors
89% of users report improved gut symptoms

Take control of how you think, feel & act with Mindset

Try for free
Self-guided hypnosis app
Developed by world-experts
Courses on anxiety, negative thinking, achieving goals & more

Get early access to our hot flashes program

Learn more
Hypnosis-based guided imagery
Menopause education
Symptom tracking & more!

Comparison of GI symptoms: Coronavirus vs IBS

Coronavirus – GI symptoms

  • Abdominal pain
  • Nausea
  • Diarrhea
  • Loss of appetite (1,5)


  • Abdominal pain
  • Nausea
  • Diarrhea (or constipation)
  • Bloating and gas (4)

How to tell IBS and COVID-19 apart

Although coronavirus and IBS may induce similar GI problems, there are several ways to tell the two conditions apart based on symptoms:

  • Respiratory symptoms. These occur in almost all (99%) of coronavirus patients and may develop up to 2 days after the onset of digestive symptoms. IBS, by contrast, does not induce respiratory symptoms. (6)
  • Loss of appetite. This symptom occurs in a high proportion (84%) of people with coronavirus but is not a symptom of IBS. (1)
  • Constipation. This symptom occurs in IBS and has not been reported as a common symptom of COVID-19. (1, 4)

By understanding the differences in symptoms, patients and doctors will be better equipped to identify COVID-19.

How does Coronavirus cause GI symptoms?

Scientists are still researching how coronavirus, which primarily infects the lungs and respiratory system, causes digestive symptoms (3). However, Chinese researchers have proposed four possible theories to explain this, suggesting the virus may:

  • Signal cells in the body to produce more liver cells, leading to an overproduction of liver cells causing inflammation and digestive problems. (7)
  • Cause inflammation throughout the body via a chain reaction, leading to digestive problems. (1)
  • Disrupt bacteria in the gut, important for many digestive functions, causing digestive symptoms. (1,8)
  • Damage the intestines and digestive system directly to cause symptoms (1)

However, further research is needed to clarify exactly how the virus causes symptoms such as loss of appetite, abdominal pain.

Can stress over the COVID-19 cause IBS?

The threat of coronavirus and worldwide lockdown is a stressful period in recent history. Research has shown that periods of stress can trigger or worsen symptoms of irritable bowel syndrome (9,10). During the coronavirus pandemic, there are several causes of stress and anxiety that may contribute to IBS including:

  • Fear of contracting the virus.
  • Loss of employment, business sales, or other income sources.
  • Fear that a family member may contract the virus.
  • Fear of dying from the virus.

Fortunately, accessible several treatment options are available that target both symptoms of stress and IBS.

Relieving stress and flare-ups triggered by the Coronavirus

If you are experiencing stress and symptoms of IBS from the stress of the coronavirus, there are several treatments acting on the mind-body connection. These therapies have been proven effective in clinical trials to lower stress levels and improve symptoms of IBS. Many of these are available at home while you are social distancing, via smartphone apps:

  • Hypnotherapy: This form of therapy involves progressive relaxation followed by suggestions of soothing imagery designed to lessen symptoms of IBS. Research has shown this therapy may reduce symptoms in up to 70% of patients. Smartphone apps such as Nerva allow direct access to hypnotherapy content. (11)
  • Mindfulness-based therapy: This therapy is thought to improve concentration, self-esteem and a reduction in the pain and anxiety associated with digestive symptoms. Apps such as Calm and Headspace provide mindfulness meditation programs. (12)
  • Cognitive-behavioral therapy (CBT): There is significant evidence showing CBT is effective to improve digestive symptoms such as pain, diarrhea, and constipation. CBT involves cognitive and behavioral techniques such as visualization, positive self-talk. (13)

What is the cause of IBS?

Similar to the GI symptoms of coronavirus, the exact cause of IBS is not known. However, it strongly co-occurs with mental health conditions such as depression and anxiety. This has lead researchers to conclude that the mind-body connection is important in the development of IBS. Risk factors for IBS include:

  • Family history of IBS (14)
  • Mental health problems (15)
  • Ongoing stress (8,9)

What other treatments are available for IBS?

Besides mind-body therapies, which work by addressing the emotional stress often underlying IBS and other functional GI disorders, there are also available medications. Since the root cause of IBS is not known, these are primarily aimed at ameliorating the symptoms of the condition. These include:

  • Probiotics: are live bacteria that can improve symptoms of IBS, as well as improve mood and reduce symptoms of anxiety. (16, 17, 18)
  • Laxatives: to treat symptoms of constipation. (19)
  • Fiber supplements: to improve symptoms of constipation. (19)

Coronavirus and GI symptoms

A study from Wuhan, China showed that gastrointestinal symptoms may start up to 2 days before flu-like symptoms as an ‘early warning’ sign. This finding was based on over 100 patients, over 50% of whom experienced GI symptoms such as loss of appetite and nausea as their primary complaint. This suggests that those who experience these symptoms should consider self-quarantining for at least 2 days. Although symptoms may be related to IBS as it is a more common condition worldwide, coronavirus may be responsible, especially if respiratory symptoms develop. (1)

It is also possible for coronavirus patients to suffer GI symptoms only. A small proportion (about 1% of patients) who contract Coronavirus suffer digestive issues but no signs of fever. However, the majority of patients experience fever, dry cough and other respiratory symptoms as their primary complaint. (6)

Unfortunately, those with digestive issues with their coronavirus experience a worse prognosis. This includes worse clinical outcomes and higher mortality rates. Patients with GI symptoms were less likely to be cured than those with respiratory symptoms. (1)

Research has also shown that coronavirus may be transmitted not only via cough droplets in the air or direct contact, but also by the fecal-oral route. In other words, virus can survive and be transmitted through poo. Scientists have proven that the virus may be transmissible in poo even when there is no sign of the virus in the infected person (20). Therefore, it is important to maintain proper hygiene practices to avoid fecal contamination on surfaces that could lead to infection. (21, 22)

GI symptoms and Coronavirus diagnosis

Coronavirus is usually diagnosed based on respiratory symptoms. However, scientists are recommending doctors assess digestive symptoms as part of the diagnosis. This is because some COVID-19 patients experience GI symptoms, with no respiratory symptoms, and other patients show GI symptoms up to 2 days before respiratory symptoms begin. (1, 23, 24)

Additionally, using a technology called reverse transcriptase-polymerase chain reaction (RT-PCR), doctors are able to analyze a poo sample for traces of viral genetic material. This allows them to rapidly diagnose a person with COVID-19, even after symptoms have ceased or no symptoms were experienced at all. (25, 26)

Is Coronavirus worse in people with inflammatory bowel diseases (IBD)?

People with pre-existing inflammatory bowel disease may be at a heightened risk of dying from coronavirus. This is because medications commonly prescribed for IBD dampen the immune system, which attacks the person’s own body. This makes them more susceptible to the impact of the virus. (27)

If you are unsure whether you have IBS or IBD, a gastroenterologist will typically perform tests to confirm the diagnosis, after a physical examination. Colonoscopy is the most definitive test for IBD and involves a thin, flexible tube with a camera attached through the anus into the digestive tract. This procedure is able to observe signs of inflammation in IBD. Scans using computerized tomography (CT) or x-ray can be used to determine if inflammation occurs in regions not observable by colonoscopy. Once IBD diagnosis is confirmed negative, then the elevated risk of coronavirus from immunosuppressive drugs can be ruled out. (28)

Can diet and exercise help me recover from Coronavirus?

Lifestyle changes such as diet and exercise have been recommended by medical experts to improve the chances of recovery. UK experts from the Centre for Perioperative Care (CPOC) recommend maintaining a healthy diet, limiting alcohol, exercising for 30 minutes per day and stopping smoking to reduce the chance of developing severe symptoms from coronavirus. This is based on evidence from China indicating those of low fitness and general health were up to five times more likely to have a worse outcome than fit and healthy people. (29)

A Word from Mindset Health

Besides respiratory symptoms, COVID-19 may cause symptoms in the GI tract. Inflammation in the small intestine and large intestine is thought to be responsible, however, further research is needed. Many GI symptoms of coronavirus overlap with IBS and diagnosis of IBS may be useful for those concerned with having contracted COVID-19.

Self-hypnosis app for sleep, anxiety & depression

Try the Mindset app
Self-guided hypnosis app
Developed by world-experts
Courses on anxiety, negative thinking, achieving goals & more

Calm your IBS in just 6 weeks with Nerva

Start Now
Self-guided gut hypnotherapy
Developed by doctors
89% of users report improved gut symptoms

Manage hot flashes naturally, at home

Get Early Access
Hypnosis-based guided imagery
Menopause education
Symptom tracking & more!

Our Sources

Mindset Health only uses high-quality sources, including peer-reviewed research, to support our articles. We work with experts to ensure our content is helpful, accurate and trustworthy.

  1. Sun, M.D., Rungsheng Wang, M.S., Junhong Yan, M.D., Pibao Li, M., Baoguang Hu, M.D. and PhD11, C., Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Link
  2. Canavan, C., West, J. and Card, T., 2014. The epidemiology of irritable bowel syndrome. Clinical epidemiology, 6, p.71. Link
  3. Dhama, K., Sharun, K., Tiwari, R., Sircar, S., Bhat, S., Malik, Y.S., Singh, K.P., Chaicumpa, W., Bonilla-Aldana, D.K. and Rodriguez-Morales, A.J., 2020. Coronavirus Disease 2019–COVID-19. Link
  4. Chey, W.D., Kurlander, J. and Eswaran, S., 2015. Irritable bowel syndrome: a clinical review. Jama, 313(9), pp.949-958. Link
  5. Zhang, Y., 2020. Gastrointestinal tract symptoms in coronavirus disease 2019: Analysis of clinical symptoms in adult patients. medRxiv. Link
  6. Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y. and Zhao, Y., 2020. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. Link
  7. Pan, L., Mu, M., Ren, H.G., Yang, P., Sun, Y. and Wang, R., 2020. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol, 20.
  8. Xiao, F., Tang, M., Zheng, X., Li, C., He, J., Hong, Z., Huang, S., Zhang, Z., Lin, X., Fang, Z. and Lai, R., 2020. Evidence for gastrointestinal infection of SARS-CoV-2. medRxiv. Link
  9. Greenwood-Van Meerveld, B. and Johnson, A.C., 2018. Mechanisms of stress-induced visceral pain. Journal of neurogastroenterology and motility, 24(1), p.7. Link
  10. Posserud, I., Agerforz, P., Ekman, R., Björnsson, E.S., Abrahamsson, H. and Simrén, M., 2004. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut, 53(8), pp.1102-1108. Link
  11. Lindfors, P., Unge, P., Arvidsson, P., Nyhlin, H., Björnsson, E., Abrahamsson, H. and Simrén, M., 2012. Effects of gut-directed hypnotherapy on IBS in different clinical settings—results from two randomized, controlled trials. American Journal of Gastroenterology, 107(2), pp.276-285. Link
  12. Garland, E.L., Gaylord, S.A., Palsson, O., Faurot, K., Mann, J.D. and Whitehead, W.E., 2012. Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations. Journal of behavioral medicine, 35(6), pp.591-602. Link
  13. Toner, B.B., 2005. Cognitive-behavioral treatment of irritable bowel syndrome. CNS spectrums, 10(11), pp.883-890. Link
  14. Kanazawa, M., Endo, Y., Whitehead, W.E., Kano, M., Hongo, M. and Fukudo, S., 2004. Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Digestive diseases and sciences, 49(6), pp.1046-1053. Link
  15. Kay, L., Jørgensen, T. and Jensen, K.H., 1994. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. Journal of internal medicine, 236(1), pp.23-30. Link
  16. Moayyedi, P., Ford, A.C., Talley, N.J., Cremonini, F., Foxx-Orenstein, A.E., Brandt, L.J. and Quigley, E.M., 2010. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut, 59(3), pp.325-332. Link
  17. Slykerman, R.F., Hood, F., Wickens, K., Thompson, J.M.D., Barthow, C., Murphy, R., Kang, J., Rowden, J., Stone, P., Crane, J. and Stanley, T., 2017. Effect of Lactobacillus rhamnosus HN001 in pregnancy on postpartum symptoms of depression and anxiety: a randomised double-blind placebo-controlled trial. EBioMedicine, 24, pp.159-165. Link
  18. Pinto-Sanchez, M.I., Hall, G.B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J.T., Martin, F.P., Cominetti, O., Welsh, C., Rieder, A. and Traynor, J., 2017. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology, 153(2), pp.448-459. Link
  19. Talley, N.J., 2003. Pharmacologic therapy for the irritable bowel syndrome. The American journal of gastroenterology, 98(4), pp.750-758. Link
  20. Zhang, J., Wang, S. and Xue, Y., 2020. Fecal specimen diagnosis 2019 Novel Coronavirus–Infected Pneumonia. Journal of Medical Virology. Link
  21. Wu, Y.C., Chen, C.S. and Chan, Y.J., 2020. Overview of the 2019 novel coronavirus (2019-nCoV): The pathogen of severe specific contagious pneumonia (SSCP). J Chin Med Assoc. Link
  22. Simonne, A., 2005. Hand hygiene and hand sanitizers. Acedido em Junho, 18, p.2009. Link
  23. Gu, J., Han, B. and Wang, J., 2020. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. Link
  24. Xiao2, F., Tang, M., Zheng, X., Li, C., He, J., Hong, Z., Huang, S., Zhang, Z., Lin, X., Fang, Z. and Lai, R., 2020. Evidence for gastrointestinal infection of SARS-CoV-2. medRxiv. Link
  25. Tang, A., Tong, Z.D., Wang, H.L., Dai, Y.X., Li, K.F., Liu, J.N., Wu, W.J., Yuan, C., Yu, M.L., Li, P. and Yan, J.B., 2020. Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China. Emerging infectious diseases, 26(6). Link
  26. Xie, C., Jiang, L., Huang, G., Pu, H., Gong, B., Lin, H., Ma, S., Chen, X., Long, B., Si, G. and Yu, H., 2020. Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests. International Journal of Infectious Diseases. Link
  27. An, P., Ji, M., Ren, H., Su, J., Kang, J., Yin, A., Zhou, Q., Shen, L., Zhao, L., Jiang, X. and Xiao, Y., 2020. Protection of 318 Inflammatory Bowel Disease Patients from the Outbreak and Rapid Spread of COVID-19 Infection in Wuhan, China. Link
  28. Bernstein, C.N., Fried, M., Krabshuis, J.H., Cohen, H., Eliakim, R., Fedail, S., Gearry, R., Goh, K.L., Hamid, S., Khan, A.G. and LeMair, A.W., 2010. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflammatory bowel diseases, 16(1), pp.112-124.# Link
  29. BBC News. 2020. Stay Fit To Fight Coronavirus, Say Medics. [online] Available at: <https://www.bbc.co.uk/news/uk-52076856> [Accessed 3 April 2020]. Link

Similar Articles

What is Mindset?

We’re glad you asked! Mindset is a hypnotherapy app for mental health & positive thinking.

Personalized to you

Learn coping skills


Created by experts

Available 24/7

Loved by thousands

Take our free IBS quiz
Start now